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ABSTRACT HIV-1 integrase (IN) is an essential enzyme for the viral replication and an interesting target for the design of new
pharmaceuticals for multidrug therapy of AIDS. Single and multiple mutations of IN at residues T66, S153, or M154 confer
degrees of resistance to several inhibitors that prevent the enzyme from performing its normal strand transfer activity. Four
different conformations of IN were chosen from a prior molecular dynamics (MD) simulation on the modeled IN T66I/M154I
catalytic core domain as starting points for additional MD studies. The aim of this article is to understand the dynamic features
that may play roles in the catalytic activity of the double mutant enzyme in the absence of any inhibitor. Moreover, we want to
verify the inﬂuence of using different starting points on the MD trajectories and associated dynamical properties. By comparison
of the trajectories obtained from these MD simulations we have demonstrated that the starting point does not affect the
conformational space explored by this protein and that the time of the simulation is long enough to achieve convergence for this
system.
INTRODUCTION
HIV-1 integrase (IN) is one of the three enzymes encoded by
the viral genome, in addition to reverse transcriptase and
protease. It has the function of catalyzing the integration of
the transcribed double-stranded viral DNA into the host
chromosome. This process occurs in two sequential reac-
tions (Brown, 1997): in the ﬁrst step, termed 39 processing,
a water molecule attacks at the 39 ends of the viral DNA
removing a dinucleotide; in the second step, called ‘‘strand
transfer’’, each exposed viral DNA 39-OH ribose is acti-
vated for nucleophilic attack to opposite strands of the host
DNA, across a ﬁve-basepair stretch, becoming covalently
attached to it.
HIV-1 IN is a 32-kDa enzyme comprised of three
structurally and functionally distinct domains, all of them
required for full catalytic activity (Engelman et al., 1993).
The N-terminal domain (residues 1–50) contains a conserved
HHCC motif (Johnson et al., 1986), which binds a Zn21 ion
(Burke et al., 1992; Bushman and Craigie, 1991; Haugan
et al., 1995; Lee and Han, 1996; Zheng et al., 1996) that
promotes the multimerization (Zheng et al., 1996) and
enhances the catalytic activity (Lee and Han, 1996; Zheng
et al., 1996). The catalytic core domain (residues 50–212)
contains the conserved D,D-35-E motif, common to all
retroviruses, retrotransposons, and some bacterial trans-
posases (Engelman and Craigie, 1992; Kulkosky et al., 1992;
Polard and Chandler, 1995; Rowland and Dyke, 1990). This
motif is represented, by the residues Asp-64, Asp-116, and
Glu-152 in HIV-1 IN that are crucial for the activity. Finally,
the C-terminal domain (residues 212–288) appears to
have a nonspeciﬁc DNA binding activity (Engelman et al.,
1994; Vink et al., 1993; Woerner and Marcus-Sekura, 1993).
All of the three isolated domains form homodimers in
solution whereas the activity of IN is mediated by a multi-
meric complex that requires the presence of at least one
integrase active site, and the conserved amino acids Asp-64,
Asp-116, and Glu-152 (Drelich et al., 1992; Engelman and
Craigie, 1992; Kulkosky et al., 1992). Either manganese (in
vitro) or magnesium (in vitro and in vivo) is essential as
a catalytic cofactor, and furthermore it has been proposed
that two of the divalent metal ions are coordinated to the
active site residues Asp-64, Asp-116, and Glu-152 (Beese
and Steitz, 1991; Ellison and Brown, 1994; Hazuda et al.,
1997; Vink et al., 1994; Wolfe et al., 1996).
Structural information is available for all three domains of
HIV-1 IN. The solution structures of the isolated N-terminal
and C-terminal domains have been determined by NMR (Cai
et al., 1997; Eijkelenboom et al., 1997, 1995; Lodi et al.,
1995). The catalytic core domain of HIV-1, simian immuno-
deﬁciency virus, and Rous sarcoma virus integrases have
been determined by x-ray crystallography as a single domain
dimer (Bujacz et al., 1995, 1996; Dyda et al., 1994; Goldgur
et al., 1998) and together with the N-terminal (Wang et al.,
2001) or C-terminal (Chen et al., 2000a,b; Yang et al., 2000)
domain. However, there is no complete structural informa-
tion about the loop region between the residues 140–145,
mainly because of its high B-factors that suggest substantial
ﬂexibility in this region. The aforementioned loop is located
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close to the active site and mutations that constrain this loop
have demonstrated that its mobility is important for catalytic
activity (Greenwald et al., 1999) and that it is involved in
stabilization of the substrate during the reaction with the
DNA substrate (Esposito and Craigie, 1998; Heuer and
Brown, 1997).
HIV-1 IN, being an essential enzyme for the viral rep-
lication, has become a very attractive target for antiretroviral
therapy after the emergence of HIV-1 strains resistant to
reverse transcriptase and protease inhibitors. One of the most
promising classes of integrase inhibitors comprises com-
pounds with a diketo acid functionality and the capability of
selective inhibition of the strand transfer reaction (Hazuda
et al., 2000). Single or multiple mutations in HIV-1 IN at
residues T66, S153, or M154 confer degrees of resistance to
one ormore compounds belonging to this class (Hazuda et al.,
2000). Given the unavailability of three-dimensional struc-
tures for the mutated enzyme and the lack of information
about the reasons why these few mutations close to the active
site confer resistance to the inhibitors, we carried out
a molecular dynamics (MD) study of the HIV-1 IN T66I/
M154I catalytic core domain. Previous MD simulations were
carried out on the wild-type HIV-1 IN catalytic core domain
as well as with (Barreca et al., 2003; Ni et al., 2001) and
without (Lins et al., 2000, 1999; Weber et al., 1998) the
inhibitor 5CITEP complexed in the active site. Another MD
simulation has been carried out on IN T66I/M154I with the
same inhibitor complexed (Barreca et al., 2003) but no
conformational study on the double mutant enzyme alone is
available. These previous MD studies showed that signiﬁcant
and apparently important conformational interactions occur
in the active region and demonstrated the importance of the
ﬂexibility of the loop containing residues 138–149. It has
been shown that the mobility of this loop in the wild-type IN
is constrained due to the presence of the 5CITEP inhibitor
within the active site (Barreca et al., 2003).
The aim of this study is to understand if there are
signiﬁcant differences in the dynamical behavior of the
mutated enzyme with respect to the previously published
(Lins et al., 2000, 1999) wild-type enzyme in terms of ﬂex-
ibility of the protein and orientation of the residues important
for the catalytic activity.
Because there is no complete IN structure available, to be
able to computationally characterize the whole structure of
the protein, it is important to understand whether the starting
conformation of an MD simulation may signiﬁcantly affect
the results. This might be particularly important for the
highly ﬂexible regions that may play a role in the catalytic
activity (Greenwald et al., 1999). To address this issue we
have performed four 2-ns MD simulations on the HIV-1 IN
catalytic core domain T66I/M154I mutant starting from four
different conformations. These conformations were selected
from a previously carried out MD simulation (Barreca et al.,
2003) by choosing the snapshots that displayed the highest
RMSD in the loop containing residues 138–149.
We show that the dynamic behavior of HIV-1 IN T66I/
M154I does not display signiﬁcant differences with respect to
the behavior of the wild-type IN described in a previous study
(Lins et al., 1999). By using essential dynamics (Daura et al.,
1999) and cluster analyses we demonstrate that the starting
structure, when it comes from molecular dynamics simu-
lations, does not affect the conformational space sampled by
this system and that within the simulation time the system is
likely to reach convergence (Smith et al., 2002).
METHODS
Structures
Four snapshots from a prior 1.8-ns MD simulation carried out on HIV-1 IN
T66I/M154I (Barreca et al., 2003) have been taken as starting points for the
minimization and equilibration protocol. The choice of the snapshots was
based on the highest difference in the root-mean-square deviation (RMSD)
of the loop region 138–149, one of the most ﬂexible parts of the protein
(Barreca et al., 2003; Lins et al., 2000, 1999), and known to play an im-
portant role in the catalytic activity (Greenwald et al., 1999).
To select the starting structures, the loop conformations were compared
over all of the MD snapshots by superimposition of their backbone atoms.
Based on examination of the loop motions, two loop conformations were
selected as being representative of the extreme positions of the range of loop
motion. Two other conformations were chosen between the two extremes,
resulting in a total of four starting structures.
Molecular dynamics simulations
All four conformations of the protein were extracted from a 1.8-ns MD
trajectory described elsewhere (Barreca et al., 2003). The protein was
solvated in a cubic box (with 7.2-nm edges) of preequilibrated waters. Water
molecules that were found to be within 0.26 nm of any atom in the solute
were removed. Two negative counterions were placed in the proximity of the
regions of the protein surface with the most favorable electrostatic potential
calculated using the particle-based method implemented in the GROMACS
(van der Spoel et al., 1994) package v3.0.5. The protein and solvent interact
via the CHARMM27 force ﬁeld where all protein atoms are explicitly
represented (MacKerell et al., 1998) and water is characterized by the TIP3P
model (Jorgensen et al., 1983; Neria et al., 1996). The hydrogen atoms of the
protein were placed using the HBUILD routine implemented in CHARMM
(Brooks et al., 1983). The SHAKE algorithm (Ryckaert et al., 1977), with
a tolerance of 107 nm, was applied to constrain all bonds involving
hydrogen atoms in all simulations.
The temperature was kept constant by coupling to a heat bath through the
Berendsen algorithm (Berendsen et al., 1984). The pressure was adjusted by
isotropic position scaling using a Berendsen-like algorithm. To avoid edge
effects, periodic boundary conditions were applied to all of the simulations.
Atomic coordinates were saved every 0.5 ps for later analysis. A 1.0-nm
short-range cutoff was used for all nonbonded interactions and long-range
electrostatic interactions were treated by the particle-mesh-Ewald method
(Essmann et al., 1995) with a grid size of 7.2 3 7.2 3 7.2 nm.
Before the MD runs were performed, the system was energy minimized
by 200 steps of steepest descent keeping the solute (protein, magnesium ion,
and chloride ions) ﬁxed, followed by 1000 steps of conjugate gradient with
no constraints. The system was heated up to 300 K over a period of 30 ps,
with a 2-fs time step and equilibrated for 70 ps with the velocities being
reassigned in the system every 0.1 ps. The system was further equilibrated,
with a 2-fs time step, for 50 ps at which point the energy of the system
achieved complete stability. Production runs were performed at 300 K and
carried out under NPT (i.e., constant number of particles, pressure and
temperature) conditions for 2 ns with a 2-fs time step.
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All MD simulations were performed using the NAMD (Kale et al., 1999)
program and analyses of the trajectories were performed using the
GROMACS software package (van der Spoel et al., 1994).
Essential dynamics
Essential dynamics (Amadei et al., 1993) is a technique that allows the
identiﬁcation of the correlated motions of a protein during a trajectory
generated by an MD simulation. After removal of the rotational motions,
a covariance matrix is constructed. The diagonalization of the matrix leads to
a set of eigenvectors/eigenvalues. Each eigenvector represents one single
direction in a multidimensional space whereas the eigenvalue is the
amplitude of the motion along the eigenvector. The Ca displacement along
each eigenvector can provide insights into the concerted motions of the
protein along each direction along with their amplitude. The projection of
the displacements on each eigenvector shows the width of the essential space
explored by the system as a function of time. A comparison of the
conformational space sampled by different trajectories generated for the
same system can be made to gain insight into the amount of essential space
explored by the system during the MD simulation. For the purpose of
comparing different trajectories, essential dynamics can be performed on
a combined trajectory, constructed by concatenating each individual
trajectory (van Alten et al., 1995). If the motions are similar, the eigenvectors
and the eigenvalues coming from individual trajectories should be similar to
the motions observed in the concatenated trajectory (van Alten et al., 1995).
Cluster analysis
Cluster analysis was performed using the GROMOS method (Daura et al.,
1999). Structures of the protein were taken from the MD trajectory at 10-ps
intervals. The matrix of atom positional root-mean-square deviations
between pairs of structures was calculated for the backbone atoms of
residues 57–208 (the catalytic core domain) of the protein and of residues
137–150 for the ﬂexible loop considered independently. The criterion of
similarity for two structures was the backbone atom positional RMSD #
0.10 nm for the backbone atoms of residues 57–208 of the protein and of
residues 137–150 for the ﬂexible loop.
This method, described in detail by Daura et al. (1999), is considered to
be an effective tool for judging the convergence of MD simulations,
especially if this analysis involves the comparison of multiple trajectories,
generated from different starting conformations of the same system (Smith
et al., 2002). The convergence of a simulation can be considered achieved
when the plot of the number of clusters as a function of time reaches a
plateau.
RESULTS AND DISCUSSION
Comparative analysis
The four 2-ns MD trajectories computed for the HIV-1
integrase double mutant (T66I/M154I) catalytic core domain
starting from different conformations have been compared
and are designated by S1, S2, S3, and S4, where S1 is the
starting conformation chosen from the 1.8-ns MD simulation
(Barreca et al., 2003) at 90 ps, S2 from 630 ps, S3 from 1160
ps, and S4 from 1650 ps. Fig. 1 shows the RMSD of the
backbone atoms with respect to the equilibrated conforma-
tion for each of the 2-ns trajectories (S1, S2, S3, S4), and
where rotational and translational motions were removed.
Each simulation rapidly achieves stability in the atom
positional RMSD with values between 0.2 and 0.3 nm.
The values of RMSD increase to ;0.15 nm after 150 ps
maintaining low structural changes for 750 ps. After 1000 ps,
the RMSD values undergo larger ﬂuctuations with respect to
the ﬁrst portion of the simulations. The relatively high values
and the irregular proﬁle of the plots reﬂect the structural
changes of highly ﬂexible protein regions. From the analysis
of the root-mean-square ﬂuctuation (RMSF) per residue
(Fig. 2) we can see that there are three loop regions that dis-
play a large ﬂexibility. These three regions comprise residues
66–74, 138–149, and 185–195. The simulations that show
a wider ﬂuctuation in atom positional root-mean-square
deviation in the region between residues 138 and 149 are S1
and S4 (Fig. 2). The difference in the values of ﬂuctuations
for the most ﬂexible regions may be explained considering
FIGURE 1 Root-mean-square deviation (RMSD) of double mutant HIV-1
IN (T66I/M154I) backbone atoms with respect to the equilibrated con-
formation as a function of time. The inset ﬁgure shows the RMSD calculated
for the protein backbone atoms after removing the contribution of the cata-
lytic loop (residues 138–149). S1 stands for simulation 1 (black solid line);
S2 stands for simulation 2 (black dotted line); S3 stands for simulation 3 (gray
solid line); and S4 stands for simulation 4 (gray dotted line).
FIGURE 2 Backbone atom RMSF per residue for the four trajectories:
S1-simulation 1 (black solid line), S2-simulation 2 (black dotted line),
S3-simulation 3 (gray solid line), and S4-simulation 4 (gray dotted line).
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how far the conformations of the starting structures of these
regions are from their most favorable conﬁguration (i.e.,
conﬁgurations after the convergence of the simulation). The
loop containing residues 138–149 has the highest difference
in ﬂuctuations among the four trajectories with respect to the
other two loop regions because the criteria for choosing the
four starting conformations was based on its highest degree
of diversity among the snapshots of the 1.8-ns MD simu-
lation (Barreca et al., 2003). Fig. 3 shows the backbone
RMSD of the loop region 138–149 calculated with respect to
each equilibrated structure. Simulations S1 and S2 are the
ones that show a wider RMSD in their loop regions with
respect to the conformation at the beginning of the pro-
duction phase (i.e., 0 ps). In particular, S1 has a large
transition in the loop conformation after 1000 ps of MD
simulation (from 0.35 to 0.7 nm), whereas a smaller tran-
sition occurs to the S2 loop that increases from 0.35 to 0.45
nm after 1500 ps. The loop shows very similar RMSD with
respect to the equilibrated structures (0 ps), for all four
structures, with the exception of the transitions mentioned
previously that occurred in the case of the S1 and S2
simulations (Fig. 3). The inset in Fig. 1 shows the backbone
RMSD of the protein after removing the contribution of the
ﬂexible loop comprised of residues 138–149. It is evident
that in this case the proﬁle is much more stable than the one
displayed for the whole protein. S1, S2, and S4 have an
almost perfect overlapping pathway whereas S3 is the
simulation with the lowest value of RMSD (Fig. 1, inset).
Moreover, the RMSD value for the S3 ﬂexible loop (see
Fig. 3) ﬂuctuates around the same average value for the
entire simulation. Therefore, the RMSD calculated for the
whole protein is extensively inﬂuenced by the catalytic loop
(residues 138–149).
The static regions of the protein overlap very well for all
four trajectories (Fig. 2), explaining that the parts of the
protein with well-deﬁned secondary structure elements do
not show particular differences in their dynamical behavior.
Fig. 4 shows the backbone RMSD per residue (with respect
to the 0-ps conformation) for the four MD simulations. This
is different for loop 138–149, which shows very different
deviations among the four equilibrated structures. This is
signiﬁcant because the difference in width of the deviation
from their conformation at the beginning of the production
run may be in agreement with the tendency of our MD
simulations to achieve convergence when starting from dif-
ferent conﬁgurations. Comparing the superimposition of the
four starting structures of double mutant IN (T66I/M154I)
with the superimposition of the four average structures
obtained after the 2-ns MD simulations we can see that the
ﬂexible loop adopts a similar conformation (Fig. 5), inde-
pendently of the starting conﬁguration.
Essential dynamics
Fig. 6 shows the plot of the eigenvector index against
eigenvalues, both derived from the covariance matrix of the
a-carbons for the four trajectories and for the concatenated
trajectory. The eigenvalue belonging to the ﬁrst eigenvector
is very similar among the four MD simulations as well as for
the combined trajectories. If the motions identiﬁed for the
combined trajectory are similar to those coming from the
individual trajectories, the eigenvalues (and eigenvectors)
should be similar. The plot indicates that the properties of the
motions described by the essential eigenvectors are almost
identical. By projecting the trajectory on each of the most
important eigenvectors (Fig. 7) the essential space explored
by the protein along each direction (eigenvector) is made
evident. In this case it is possible to understand the most
important eigenvectors for the essential motions of the
protein and to compare the essential space explored by the
four trajectories. In Fig. 7 the four eigenvectors that deﬁne
the essential space (i.e., four essential degrees of freedom
FIGURE 3 Root-mean-square deviation of the backbone atoms of the
catalytic loop (residues 138–149) as a function of time with respect to the
equilibrated conformation (0 ps). S1 stands for simulation 1 (black solid
line); S2 stands for simulation 2 (black dotted line); S3 stands for simulation
3 (gray solid line); and S4 stands for simulation 4 (gray dotted line).
FIGURE 4 Backbone RMSD per residue with respect to the equilibrated
conformation (0 ps): S1 (black solid line), S2 (black dotted line), S3 (gray
solid line), and S4 (gray dotted line).
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out of 462) are displayed. The pathway followed by each
trajectory for the exploration of the essential space is
different because the starting conformations of the MD
simulations are different. Nevertheless, the range of con-
formational space explored along each eigenvector is very
similar for all four trajectories. Fig. 8 shows the a-carbon
displacement along the four main eigenvectors. The essen-
tial motions identiﬁed are very similar for all four MD
simulations. These motions are also well correlated with the
Ca displacement obtained from the concatenated trajectory.
The most ﬂexible regions comprise residues 138–149 and
185–195 for all of the ﬁrst four eigenvectors, indicating that
these regions are exploring a wide conformational space
because their motions have large amplitude along all of the
four most important directions of the essential space.
Cluster analysis
The cluster analysis probes the dependence of the results on
the initial structure used for the simulation (Laboulais et al.,
2002). The convergence of different trajectories calculated
by MD simulations may be an artifact due to a too-short time
of conformational sampling. Because the ﬂexible loop
comprising residues 138–149 is of primary importance for
catalytic activity (Greenwald et al., 1999), we also performed
a cluster analysis on this part of the protein. However, we
chose the region from residue 137 to residue 150. By doing
so, we attempted to avoid end effects by treating this part of
the protein as a 14-residue peptide.
Fig. 9 shows the total number of clusters as a function of
cumulative time for the entire protein. This quantity provides
information about how much conformational space has been
populated in the simulation. All of the simulations show
a limited sampling either because of the low temperature or
because of the well-deﬁned secondary structure of the
system. The total number of clusters identiﬁed for the four
simulations is very similar; 32 clusters were found for S1,
S2, S4, and 37 for S3. From Fig. 9 we can see that there are
overlaps in the number of clusters over all of the trajectories.
Such an overlap may indicate that the conformational space
accessible by the system is similar for all of the MD
simulations regardless of the starting conformation; how-
ever, this is only true if the conformations in the clusters
identiﬁed in one simulation are similar to those in the other
one. The conformational sampling increases slightly during
the ﬁrst 1.4 ns for S2, S3, and S4 and during the ﬁrst 1.0 ns
for S1. After these times, the number of clusters identiﬁed
decreases and seems to reach a stable value for the last
0.25 ns. Note that a decrease in the number of clusters is pos-
sible because all clusters are redeﬁned at each analysis point
(i.e., every 200 ps). For example, conformations that were
members of two separate clusters in a prior analysis point
may later be merged into one cluster due to nearby sampling,
resulting in a reduction in the total number of clusters. It
can be seen in the overlay of the four trajectories in Fig. 9
that all of them converge to approximately eight clusters
revealing that 2 ns of explicit solvent simulation at 300 K
does not allow the protein to access wider conformational
sampling.
FIGURE 6 Eigenvalues derived from the covariance matrices of the four
MD simulations: S1 (black solid line, circles); S2 (black dotted line,
squares); S3 (gray solid line, triangles); S4 (gray dotted line, stars);
concatenated trajectories (black dashed line, diamonds).
FIGURE 5 (a) Superposition of the four starting
snapshots (S1, S2, S3, and S4); (b) average structures
calculated for the four trajectories (S1, S2, S3, and S4).
The conformations of the loop region comprised of
residues 138–149 are displayed as solid ribbon.
3076 Brigo et al.
Biophysical Journal 88(5) 3072–3082
To demonstrate that the conformational space explored by
the protein during the four MD simulations is correlated,
a comparison of the clusters with a minimum of three mem-
ber conformations was carried out as follows: the average
conformation was calculated for every cluster (22 clusters for
each MD simulation contained three or more conforma-
tions), and the RMSD was computed with respect to a
reference structure (i.e., starting conformation of the MD
simulation carried out on the IN double mutant T66I/M154I
by Barreca et al., 2003). The values of RMSD were next
compared for every cluster and their standard deviations
were calculated. Fig. 10 shows the standard deviation values
for each of the 22 clusters identiﬁed for all of the four MD
simulations. The average structures of the majority of the
clusters are similar as indicated by the low values of the
standard deviation, largely between 0.21 and 0.46. This
demonstrates that there is a good correlation among the
conformations collected in each cluster obtained by the MD
simulations starting from different conformations. Higher
standard deviation values for clusters 2, 9, 14, and 16 (Fig.
10), respectively, of 0.52, 0.65, 0.58, and 0.51, are due to
only one value of RMSD out of the four used to calculate the
standard deviation within each cluster. However, the three
remaining values of RMSD are quite similar (note that the
RMSD values are calculated between the average confor-
mation of each cluster and a reference structure, in this case
the starting conformation of the MD simulation carried out
on the IN double mutant T66I/M154I by Barreca et al.,
2003).
Fig. 11 shows the number of clusters identiﬁed for the
ﬂexible loop region (between residues 137–150), considered
as a 14-residue peptide. Given the relatively high ﬂexibility
of the loop it is surprising that the total number of clusters
identiﬁed is between 8 (S1) and 18 (S4). The higher number
of clusters found for the S4 simulation is reasonable given
that the ﬂexible loop shows the highest ﬂuctuation during
FIGURE 7 Projections of the four simulations (S1,
black solid line; S2, black dotted line; S3, gray solid
line; S4, gray dotted line) on the four selected eigen-
vectors.
FIGURE 8 Residue displacement calculated for
each Ca atom along the four selected eigenvectors:
S1 (black solid line); S2 (black dotted line); S3 (gray
solid line), and S4 (gray dotted line).
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this trajectory (see Fig. 2). The plot shows a disordered
conformational sampling for the loop, with no increase
throughout all of the MD simulations. Between 1.0 and 1.5
ns there are many overlaps in the explored conformational
space, demonstrating that similar conformational sampling
takes place for loop 138–149 in all four trajectories. After
1.6 ns, the sampling seems to reach a more stable proﬁle.
Conformational characteristics of HIV-1
integrase T66I/M154I
We have previously reported the results of MD simulations
for the catalytic core domain of HIV-1 integrase wild type
(Lins et al., 2000, 1999; Weber et al., 1998) and double
mutant T66I/M154I with the inhibitor 5CITEP in complex
(Barreca et al., 2003). In this work we have performed four
2-ns MD simulations on the double mutant enzyme but with
no inhibitor present.
The dynamic behavior of the double mutant system shows
the same general characteristics described for the wild type
(Lins et al., 2000, 1999) and for the double mutant with
5CITEP (Barreca et al., 2003). The analysis of ﬂexibility
shows that there are three regions of the protein (comprising
residues 66–74, 138–149, and 185–195) having higher
mobility (Figs. 2 and 8) than the rest of the protein. This
result is in perfect agreement with the results obtained on the
wild type (Lins et al., 2000, 1999) and on the double mutant
complex (Barreca et al., 2003), as well as with the crys-
tallographic data (Bujacz et al., 1995; Dyda et al., 1994).
Barreca et al. (2003) proposed that the restraint of the
ﬂexibility of this loop caused by the 5CITEP in complex
with wild type IN is one of the mechanisms of inhibition.
Our results constitute further evidence for this hypothesis
because the mobility of the loop is not inﬂuenced by the
mutations in the absence of inhibitor.
The secondary structure analysis carried out with the
DSSP algorithm (Kabsch and Sandler, 1983) shows con-
servative secondary structural elements (see Supplementary
Material), without the extension of the helix a-4 identiﬁed
by Lins et al. (1999) for the IN wild type. The ﬂexible
loop, comprising residues 138–149, shows, as expected, a
random coil conformation for the entire length of the sim-
ulation.
The active site has three essential residues, namely Asp-
64, Asp-116, and Glu-152. A magnesium ion, that works as
a cofactor for IN, is bridging the two catalytic residues Asp-
64 and Asp-116. We have monitored the relative distances
among the three catalytic residues during the simulation and
FIGURE 9 Number of clusters as a function of cumulative time,
calculated for the entire protein. S1 (black solid line, circles); S2 (black
dotted line, squares); S3 (gray solid line, triangles); S4 (gray dotted line,
stars).
FIGURE 10 Comparison of clusters with a minimum of three member
conformations for simulations S1, S2, S3, and S4. The RMSD between the
average conformation of each cluster and a reference structure (the
equilibrated structure of the prior MD simulation carried out on IN T66I/
M154I by Barreca et al., 2003) has been calculated; these RMSD values
within each single cluster have been compared by calculating their standard
deviation.
FIGURE 11 Number of clusters as a function of cumulative time,
calculated for the catalytic loop (from residue 137 to residue 150). S1
(black solid line, circles), S2 (black dotted line, squares), S3 (gray solid line,
triangles), S4 (gray dotted line, stars).
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the side-chain dihedral angles (data not shown). They do not
undergo signiﬁcant variations in their relative orientations,
showing high stability during the 2-ns production run. We
also monitored the dihedral angle variations for the residues
that have been identiﬁed to be important for the biological
activity such as Gln-62, Tyr-143, Gln-148, Asn-155, Lys-
156, and Lys-159 (Barreca et al., 2003; Lins et al., 1999).
The Gln-62 side chain moves toward residue Asp-116 after
;750 ps, maintaining the orientation for the remaining 1250
ps. The analysis of the dihedral angles x1 and x3 has shown
that after 750 ps, dihedral angles changed in such a way as to
allow this residue to make hydrogen bonds with the Asp-116
side chain. When the distance between these two residues is
not within a hydrogen-bonding distance, a water molecule
bridges the two side chains, keeping the Gln-62 orientation
stable. This residue is important for the interaction with
diketo-enolic compounds, because it is involved in the
formation of a cleft occupied by 5CITEP (Barreca et al.,
2003). Moreover, Gln-62 has been shown to be important in
the formation of a hydrogen-bonding network that causes
rigidity of the catalytic loop in the wild-type IN (Barreca
et al., 2003). In our simulations the side chain of Gln-62
exhibits a stable distance from D116 (after 750 ps) and
Glu-152 (data not shown). On the contrary, the distance be-
tween Gln-62 and Gln-148 (one of the catalytic loop residues)
is not stable and its value does not allow the formation of the
hydrogen bond between Gln-62 and Gln-148, which is con-
sidered responsible for the stabilization of the loop in wild-
type IN (Barreca et al., 2003).
Other MD simulations carried out on the same system in
complex with the Merck inhibitor L-731,988 (Hazuda et al.,
2000) have demonstrated that Gln-62 is very important in
stabilizing the interaction of the inhibitor with the protein
(Brigo et al., 2005).
Tyr-143 is a residue in the active site loop, which has been
proposed to play an important role in the catalytic activity
(Chen et al., 2000a; Esposito and Craigie, 1998; Lins et al.,
1999). In our simulations its side chain is always pointing
away from the active site (Fig. 12). Only occasionally it has
shown to be involved in hydrogen bonds with the side chain
of Glu-152 when the conformation of the loop was favorable
for this interaction. Given the mobility of the loop, no con-
servative interaction between this residue and any other
protein residue has been found.
CONCLUSIONS
In this study, we have analyzed in detail the dynamic
behavior of double mutant HIV-1 IN (T66I/M154I) with no
inhibitor, in an effort to understand if differences exist with
respect to previously published results for wild-type
integrase (Barreca et al., 2003; Lins et al., 1999) and on
the double mutant in complex with the 5CITEP inhibitor
(Barreca et al., 2003). The analyses have been focused on the
catalytic loop consisting of residues 138–149, whose ﬂex-
ibility has been demonstrated to play an important role in the
catalytic activity (Greenwald et al., 1999). We found a very
high mobility of this region, in agreement with the values of
ﬂexibility found for the same region in the wild-type
integrase alone (Lins et al., 1999) and of the same double
mutant in complex with the inhibitor 5CITEP (Barreca et al.,
2003). Double mutant IN (T66I/M154I) showed high
ﬂexibility of the catalytic loop in the inhibitor bound state.
This protein alone maintains the same ﬂexibility features of
the wild type and the same secondary structure elements,
implying that the mutations do not lead to major conforma-
tional changes but only to the resistance to the inhibitory
activity of the diketo-enolic acid compounds (Hazuda et al.,
2000). In our simulations, the double mutant integrase
behaves like the wild type maintaining its catalytic activity
and, presumably, its capability of forming either the active
multimeric complex (Engelman et al., 1993) or the protein-
substrate interactions. These results constitute further
evidence of the importance of the active site loop (138–
149) for the catalytic activity of the enzyme, because the
comparison of several MD simulations demonstrated
different behaviors of this region. The data reported by
Barreca et al. (2003) together with the results discussed
herein, might indirectly lead to the understanding of the
mechanism of inhibition of compounds belonging to the
diketo-acid chemical class (Hazuda et al., 2000). Because the
only differences in the dynamic behavior of IN revealed by
already-published studies as well as by ongoing further
comparative MD simulations (Brigo et al., 2005) are related
to the catalytic loop ﬂexibility, which is low only in the WT
IN in complex with 5CITEP. The preservation of loop
ﬂexibility in the DM IN in complex with 5CITEP (Barreca
et al., 2003) and with L-731,988 (Brigo et al., 2005) clearly
demonstrates that the mutations have as primary effect
FIGURE 12 Superposition of the average structures obtained from the
four trajectories (S1, S2, S3, and S4). Residues Asp-64, Asp-116, Glu-152,
and Tyr-143 are represented as sticks. The ﬂexible loop comprised between
residues 138 and 149 is represented as ribbon.
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a slight modiﬁcation of the binding mode of these diketo
acid inhibitors (Barreca et al., 2003; Brigo et al., 2005).
This change in the molecular recognition of this class of
compounds allows the enzyme to reestablish its catalytic
loop ﬂexibility that seems to be an essential condition for the
enzyme to carry out its catalytic activity. From the published
drug-resistance data (Hazuda et al., 2000) it is evident that
a diketo acid inhibitor can still bind within the DM IN active
site but with a lower afﬁnity (Brigo et al., 2005). The lower
binding afﬁnity of DM IN for diketo acids inhibitors has
also a reﬂection in the molecular recognition of the DNA
substrate (Lee and Robinson, 2004). The single mutation
M154I is capable of signiﬁcantly increasing the catalytic
activity of the enzyme (Lee and Robinson, 2004) and of
conferring some degrees of resistance to the diketo acid
inhibitors (Hazuda et al., 2000). On the other hand, the single
mutation T66I confers a slightly higher resistance to the
diketo acids (Hazuda et al., 2000) but, at the same time, it
attenuates the catalytic activity (Lee and Robinson, 2004).
The double mutation T66I/M154I described herein decreases
the catalytic activity of the enzyme (Lee and Robinson,
2004) but confers an almost threefold increase of inhibitor
resistance (Hazuda et al., 2000). These data demonstrate that
the pressure given by the inhibitors to the virus induces
mutations that lead to a decrease in catalytic activity
efﬁciency. Under the structural point of view, we demon-
strated that the overall dynamical behavior of the enzyme is
not affected by the double mutation. The real mechanism of
resistance seems to depend on the modiﬁcation of intra-
molecular hydrogen bonds (Barreca et al., 2003) and on the
orientation of active-site residue side chains, such as Gln-62,
Tyr-143, Gln-148, Asn-155, Lys-156, and Lys-159 (Brigo
et al., 2005; Barreca et al., 2003) that lead to a nonproductive
interaction between the enzyme and the diketo acid inhibitor
(Brigo et al., 2005; Barreca et al., 2003). The variation in the
binding mode of this class of compounds allows the enzyme
to reestablish its catalytic loop ﬂexibility. On the other hand,
the orientation of the aforementioned side chains is also very
important for the catalytic activity of the double mutant IN
that results signiﬁcantly attenuated (Lee and Robinson,
2004).
In this contribution we show that MD simulations carried
out on systems with well-deﬁned secondary structure
elements lead to perfectly comparable results. The RMSFs
per residue are almost identical for the regions with limited
ﬂexibility, whereas some differences are shown for the three
ﬂexible loops due to the different pathways they took toward
convergence. Essential dynamics analyses have shown that
the motions along each of the most signiﬁcant eigenvectors
are also similar and that the essential space explored by the
system is alike regardless of their different pathways. The
cluster analysis demonstrates that the time of simulation we
used allows the systems to explore the same conformational
space. However, the convergence of MD simulations carried
out starting from conformations obtained from methods such
as simulated annealing that covers a wider range of free
energy should be veriﬁed. In this article we wish to point out
that molecular dynamics simulations carried out on small
proteins without signiﬁcant conformational disorder (i.e.,
well-deﬁned secondary structure elements), such as the
HIV-1 integrase catalytic domain, starting from different
MD simulations snapshots, do not show signiﬁcant differ-
ences either in the conformational sampling or dynamic
behavior. Comparison between the trajectories studied
herein showed that the similarity of the quantities analyzed
provides a reasonable way of demonstrating the reproduc-
ibility of MD simulations.
SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
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